🇺🇸 FDA
Pipeline program

LN-144

CASE4622

Phase 1 mab terminated

Quick answer

LN-144 for Stage IIIB Melanoma is a Phase 1 program (mab) at IOVANCE BIOTHERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
IOVANCE BIOTHERAPEUTICS, INC.
Indication
Stage IIIB Melanoma
Phase
Phase 1
Modality
mab
Status
terminated

Clinical trials